Privacy Policy

Privacy Policy

Privacy Policy

Last updated 26th May, 2025

Last updated 26th May, 2025

Last updated 26th May, 2025

Who We Are

This privacy policy applies to alvb.no and describes how we collect, use, and protect your personal information.

Information We Collect

Information You Provide

  • Contact details when you reach out to us (name, email, phone number)

  • Any information you voluntarily submit through contact forms or communications

Automatically Collected Information

  • Basic website analytics (page views, browser type, IP address)

  • Cookies for essential website functionality

How We Use Your Information

We use your personal information to:

  • Respond to your inquiries and communications

  • Improve our website and services

  • Comply with legal obligations

We do not sell, rent, or share your personal information with third parties for marketing purposes.

Data Storage and Security

  • Your data is stored securely using industry-standard encryption

  • We retain your information only as long as necessary for the purposes outlined above

  • We implement appropriate technical and organizational measures to protect your data

Your Rights (GDPR)

You have the right to:

  • Access your personal data

  • Correct inaccurate information

  • Request deletion of your data

  • Object to processing

  • Data portability

  • Withdraw consent at any time

Cookies

We use essential cookies necessary for website functionality. You can control cookie settings through your browser preferences.

Third-Party Services

We may use trusted third-party services (such as web analytics or hosting providers) that have their own privacy policies. We ensure these services maintain adequate data protection standards.

Changes to This Policy

We may update this privacy policy from time to time. Any changes will be posted on this page with an updated revision date.

Contact Us

If you have questions about this privacy policy or wish to exercise your rights, please contact us at:

Email: contact@alvb.no
Address: Pløens Gate 7 Oslo, Norway 0176
Phone: +47 4067 1609

This privacy policy is designed to comply with the General Data Protection Regulation (GDPR) and Norwegian privacy laws.

Alv B AS is a registered company in Norway (Org.nr. 924 846 208). The company is authorized under the Norwegian Medicines Agency and operates in compliance with the Norwegian Animal Welfare Act. Alv B AS is authorized by the Norwegian Food Safety Authority (Mattilsynet) for conducting clinical trials in veterinary medicine (Approval No. MT-2023-0845). All research and development activities are conducted in accordance with Norwegian biotechnology regulations and international standards for comparative oncology research.

Today Dogs, Tomorrow Humans.

Through development of new treatment methods, research and data products will Alv B create value for our shareholders.

Today Dogs, Tomorrow Humans.

Through development of new treatment methods, research and data products will Alv B create value for our shareholders.

Today Dogs, Tomorrow Humans.

Through development of new treatment methods, research and data products will Alv B create value for our shareholders.

Alv B AS is a Norwegian biotech company that develops cutting-edge, cost-effective cancer treatments for dogs. We benefit from a forward-thinking team well-versed in the latest advances in cancer research on humans, as well as dogs.

Alv B AS Copyright 2025 © All Right Reserved.

Alv B AS is a registered company in Norway (Org.nr. 924 846 208). The company is authorized under the Norwegian Medicines Agency and operates in compliance with the Norwegian Animal Welfare Act. Alv B AS is authorized by the Norwegian Food Safety Authority (Mattilsynet) for conducting clinical trials in veterinary medicine (Approval No. MT-2023-0845). All research and development activities are conducted in accordance with Norwegian biotechnology regulations and international standards for comparative oncology research.

Alv B AS is a Norwegian biotech company that develops cutting-edge, cost-effective cancer treatments for dogs. We benefit from a forward-thinking team well-versed in the latest advances in cancer research on humans, as well as dogs.

Alv B AS Copyright 2025 © All Right Reserved.

Alv B AS is a registered company in Norway (Org.nr. 924 846 208). The company is authorized under the Norwegian Medicines Agency and operates in compliance with the Norwegian Animal Welfare Act. Alv B AS is authorized by the Norwegian Food Safety Authority (Mattilsynet) for conducting clinical trials in veterinary medicine (Approval No. MT-2023-0845). All research and development activities are conducted in accordance with Norwegian biotechnology regulations and international standards for comparative oncology research.

Alv B AS is a Norwegian biotech company that develops cutting-edge, cost-effective cancer treatments for dogs. We benefit from a forward-thinking team well-versed in the latest advances in cancer research on humans, as well as dogs.

Alv B AS Copyright 2025 © All Right Reserved.

Alv B AS is a registered company in Norway (Org.nr. 924 846 208). The company is authorized under the Norwegian Medicines Agency and operates in compliance with the Norwegian Animal Welfare Act. Alv B AS is authorized by the Norwegian Food Safety Authority (Mattilsynet) for conducting clinical trials in veterinary medicine (Approval No. MT-2023-0845). All research and development activities are conducted in accordance with Norwegian biotechnology regulations and international standards for comparative oncology research.